Research Studies
SAGE-301 PURVIEW
Criteria
About this study
This Phase 3 clinical trial is open to both participants who have previously been participating in the Dimension or Surveyor studies, as well as those who have not. The study is currently enrolling patients for its open label phase to receive the investigational drug, SAGE-718